Matricelf Ltd. (TASE: MTLF) Signs MOU to Establish Subsidiary for Commercialization of Parkinson’s Disease Therapy
NESS ZIONA, Israel, March 3, 2026 /PRNewswire/ — Matricelf Ltd. (TASE: MTLF), a biotechnology company developing autologous engineered tissue therapies, today…
